anxiety - Nursing Case Study
Pathophysiology
• Primary mechanism: Anxiety is primarily driven by dysregulation of neurotransmitters in the brain, particularly increased activity of excitatory neurotransmitters like glutamate and decreased inhibitory neurotransmitters such as GABA. This imbalance heightens neuronal excitability and leads to the heightened state of alertness and worry characteristic of anxiety.
• Secondary mechanism: The hypothalamic-pituitary-adrenal (HPA) axis plays a crucial role by releasing stress hormones, especially cortisol, in response to perceived threats. Chronic activation of the HPA axis due to sustained anxiety can lead to persistent cortisol elevation, which affects mood regulation and exacerbates anxiety symptoms.
• Key complication: Prolonged anxiety can lead to structural and functional changes in brain areas such as the amygdala and prefrontal cortex, potentially impairing emotional regulation and increasing vulnerability to chronic anxiety disorders.
Patient Profile
Demographics:
32-year-old female, high school teacher
History:
• Key past medical history: Generalized Anxiety Disorder (diagnosed 3 years ago), episodic migraines
• Current medications: Sertraline 50 mg daily, occasional use of Sumatriptan for migraines
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increased anxiety and difficulty concentrating
• Key symptoms: Persistent worry, restlessness, fatigue, occasional palpitations
• Vital signs: Blood pressure 145/90 mmHg, heart rate 102 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F
Section 1
During her follow-up appointment, the patient reports a significant increase in her anxiety symptoms over the past several weeks. She describes a more pronounced difficulty in concentrating at work, which has led to increased stress about her job performance. Additionally, she mentions new-onset headaches that differ from her usual migraines, characterized by a constant, dull pressure that is not relieved by Sumatriptan. On examination, her vital signs indicate sustained elevated blood pressure at 150/92 mmHg and a tachycardic heart rate of 105 bpm. The patient appears visibly fatigued, with noticeable dark circles under her eyes, indicating possible sleep disturbances.
Laboratory tests are conducted to explore underlying physiological contributors to her symptoms. The results reveal a slightly elevated cortisol level, suggesting chronic activation of the HPA axis. Thyroid function tests show normal TSH and T4 levels, ruling out hyperthyroidism as a cause of her palpitations and anxiety exacerbation. A complete blood count indicates mild anemia, which could contribute to her fatigue and concentration issues. Given these findings, there is a need to assess her lifestyle, sleep patterns, and dietary habits, which may be influencing her overall health and exacerbating her anxiety symptoms.
The healthcare team decides to adjust her treatment plan, considering her current medication may not be sufficiently controlling her anxiety. They discuss increasing her Sertraline dosage cautiously while implementing cognitive-behavioral therapy (CBT) to address her anxiety and stress management. The team also recommends dietary modifications and iron supplementation to address her anemia. The plan includes regular follow-up appointments to monitor her blood pressure, heart rate, and overall response to these interventions, emphasizing the importance of a multidisciplinary approach to her care.
Section 2
Several weeks into the revised treatment plan, the patient returns for a follow-up appointment. She reports some improvement in her anxiety symptoms with the increased dosage of Sertraline, noting a slight decrease in the frequency and intensity of her anxiety episodes. However, her primary concern now is the persistence of her headaches and the continued difficulty in concentrating at work. She describes the headaches as being more frequent and often accompanied by a sensation of tightness around her temples. Additionally, she mentions experiencing intermittent dizziness and a sensation of palpitations, which are particularly pronounced during stressful situations at work.
On examination, her vital signs reveal a blood pressure of 148/90 mmHg and a heart rate of 98 bpm, indicating a slight improvement but still elevated levels. The patient appears less fatigued, but she continues to have dark circles under her eyes, suggesting ongoing sleep disturbances. Upon further assessment, she admits to having irregular sleep patterns, often staying up late to complete work tasks and using caffeine to stay awake during the day, which could be contributing to her symptoms. Her dietary recall reveals inconsistent meal patterns and a tendency to skip breakfast, which could be affecting her anemia management.
The healthcare team discusses these findings and considers the possibility that the patient's lifestyle habits may be undermining the effectiveness of her treatment. They emphasize the need for regular sleep hygiene practices and suggest a structured bedtime routine to improve her sleep quality. The team also recommends reducing caffeine intake and establishing a balanced meal schedule to support her overall health and potentially alleviate her headaches and dizziness. The plan includes a referral to a nutritionist for personalized dietary advice, as well as a follow-up with a neurologist to further investigate the nature of her headaches, ensuring a comprehensive approach to her care.
Section 3
Several weeks after implementing the revised treatment plan and lifestyle adjustments, the patient returns for another follow-up appointment. During this visit, she reports some improvement in her sleep quality after adopting the suggested bedtime routine and reducing her caffeine intake. However, she continues to experience frequent headaches and dizziness, which now seem more unpredictable and bothersome. She also mentions an increase in palpitations, particularly during the afternoon, often accompanied by mild shortness of breath and a feeling of unease.
The healthcare team conducts an updated assessment and notes her vital signs: blood pressure is now 152/94 mmHg, and her heart rate is 105 bpm, both of which are elevated from the previous visit. A thorough physical examination reveals mild pallor and slight tremors in her hands. Laboratory results show low hemoglobin levels at 10.5 g/dL, indicating persistent anemia. Additionally, her thyroid function tests reveal a slightly elevated TSH level at 4.8 mIU/L, suggesting potential subclinical hypothyroidism.
Given these findings, the healthcare team considers the possibility that her symptoms may be multifaceted, involving both anxiety and an underlying thyroid disorder that could be exacerbating her cardiovascular symptoms. They decide to adjust her treatment plan by consulting with an endocrinologist to evaluate the need for thyroid hormone therapy. The team also emphasizes the importance of consistent follow-up to monitor her blood pressure and heart rate closely. These steps aim to address the interconnected aspects of her condition, providing a more comprehensive approach to her ongoing care.
Section 4
The patient returns for a follow-up appointment two weeks after the consultation with the endocrinologist. During this visit, she reports that she has started on a low dose of levothyroxine to address the subclinical hypothyroidism. While she notes slight improvement in her energy levels, she continues to experience frequent palpitations and dizziness, particularly in the late afternoon. She also mentions feeling more fatigued than usual despite the improved sleep pattern.
Her vital signs show a blood pressure of 148/92 mmHg and a heart rate of 98 bpm, indicating a slight improvement but still remaining elevated. A repeat physical examination reveals persistent mild pallor and slight hand tremors. Her hemoglobin level has improved marginally to 11.0 g/dL, but her TSH level remains elevated at 4.5 mIU/L, suggesting that the thyroid hormone therapy may need further adjustment. The healthcare team also notes a new finding: her serum ferritin level is low at 15 ng/mL, pointing to a possible iron deficiency that may be contributing to her anemia and fatigue.
The team recognizes that while the initial interventions have addressed some aspects of her condition, the persistence of her symptoms and the new laboratory findings highlight the need for further adjustments in her treatment plan. They decide to initiate iron supplementation to address the suspected iron deficiency anemia and recommend dietary modifications to support her overall nutritional status. Additionally, they plan to re-evaluate her thyroid function in a few weeks to determine if any further adjustments in her thyroid medication are necessary. These steps are essential to manage the complex interplay of her symptoms and improve her overall well-being.
Section 5
Two weeks after initiating iron supplementation and dietary modifications, the patient returns for another follow-up appointment. She reports a slight improvement in her energy levels but continues to experience frequent episodes of dizziness and palpitations. Notably, she mentions that these symptoms now appear more sporadically throughout the day, sometimes even in the morning. Her fatigue persists, although her sleep has remained consistent.
During the clinical evaluation, her vital signs reveal a blood pressure of 142/88 mmHg and a heart rate of 96 bpm, which are slightly improved but still not within the desired range. Her physical examination shows a reduction in hand tremors, but mild pallor remains evident. Laboratory tests indicate that her hemoglobin level has risen to 11.5 g/dL, suggesting a positive response to the iron supplementation. However, her TSH level is still elevated at 4.0 mIU/L, and her serum ferritin level has increased only marginally to 18 ng/mL, indicating that the iron deficiency is not yet fully resolved.
Given the persistence of her symptoms and only partial improvement in her laboratory markers, the healthcare team considers the interaction between her thyroid dysfunction and iron deficiency. They decide to increase the dosage of levothyroxine slightly, with careful monitoring to avoid overcorrection, while continuing the iron supplementation. Additionally, they plan to conduct a more comprehensive nutritional assessment to rule out any other deficiencies that could be contributing to her ongoing symptoms. These measures aim to address the multifactorial nature of her condition and optimize her treatment plan for better symptom control and overall health improvement.